RWD Study in HER2+ mBC Patients in Third-Line Therapy
Completed
- Conditions
- Breast Cancer Stage IV
- Interventions
- Other: No intervention
- First Posted Date
- 2020-09-28
- Last Posted Date
- 2021-10-07
- Lead Sponsor
- Exactis Innovation
- Target Recruit Count
- 63
- Registration Number
- NCT04566458
- Locations
- 🇨🇦
The Moncton Hospital, Moncton, New Brunswick, Canada
🇨🇦The Ottawa Hospital, Ottawa, Ontario, Canada
🇨🇦CHUM- Centre hospitalier de l'universite de Montreal, Montreal, Quebec, Canada
An Observational Study to Evaluate the Clinical Utility of the Oncomine Precision Assay Within the Exactis Network
Completed
- Conditions
- NSCLC
- First Posted Date
- 2020-09-25
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Exactis Innovation
- Target Recruit Count
- 100
- Registration Number
- NCT04564079
- Locations
- 🇨🇦
Centre hospitalier universitaire Dr-Georges-L.-Dumont, Moncton, New Brunswick, Canada
🇨🇦The Moncton Hospital, Moncton, New Brunswick, Canada
🇨🇦The Ottawa Hospital, Ottawa, Ontario, Canada
Personalize My Treatment (PMT) Registry
Suspended
- Conditions
- Cancer
- First Posted Date
- 2015-02-04
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Exactis Innovation
- Target Recruit Count
- 10000
- Registration Number
- NCT02355171
- Locations
- 🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦Cross Cancer Institute, Edmonton, Alberta, Canada
🇨🇦Centre Hospitalier Universitaire Dr-Georges-L.-Dumont, Moncton, New Brunswick, Canada
© Copyright 2025. All Rights Reserved by MedPath